Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shashank Joshi

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Indian Journal of Endocrinology and Metabolism|October 2, 2015
Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort studySunil Gupta, Kavita Gupta, R Ravi, et al.
Lung India : Official Organ of Indian Chest Society|April 3, 2023
Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence studyShambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, et al.
Lung India : Official Organ of Indian Chest Society|October 3, 2023
Author's responseShambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Randomized, Double-blind, Phase III Trial of Lobeglitazone Add-on to Metformin in Type 2 Diabetes (SENSITIZE INDIA)Shashank Joshi, Monika Tandon, Rahul Kodgule, et al.
Frontiers in Endocrinology|December 5, 2024
Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic controlParamesh Shamanna, Shashank Joshi, Mohamed Thajudeen, et al.
Journal of Technology in Behavioral Science|April 4, 2022
High School Educator Training by Simulation to Address Emotional and Behavioral Concerns in School Settings: A Randomized StudyGlenn Albright, Mina Fazel, Nikita Khalid, et al.
The Journal of the Association of Physicians of India|October 11, 2024
Blue Index as a Comprehensive, Patient-centered Assessment of Care in Diabetic PatientsRupak Chatterjee, Arindam Naskar, Shambo Samrat Samajdar, et al.
Diabetes Technology & Therapeutics|October 22, 2013
A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI)Rajendrakumar H Jani, Vikas Pai, Pramod Jha, et al.
The Journal of the Association of Physicians of India|September 16, 2025
Ribavirin and IVIG Therapy for Severe hMPV Pneumonia: A Promising Therapeutic Approach for IndiaShambo S Samajdar, Rupak Chatterjee, Shatavisa Mukherjee, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 1, 2023
Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled StudyShashank Joshi, Paramesh Shamanna, Mala Dharmalingam, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Indian Journal of Endocrinology and Metabolism|October 2, 2015
Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort studySunil Gupta, Kavita Gupta, R Ravi, et al.
Lung India : Official Organ of Indian Chest Society|April 3, 2023
Effectiveness of budesonide formoterol fixed-dose combination MDI in reducing cough symptoms in COVID-19 patients: A real-world evidence studyShambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, et al.
Lung India : Official Organ of Indian Chest Society|October 3, 2023
Author's responseShambo Samrat Samajdar, Shatavisa Mukherjee, Saibal Moitra, et al.
The Journal of the Association of Physicians of India|May 13, 2024
Randomized, Double-blind, Phase III Trial of Lobeglitazone Add-on to Metformin in Type 2 Diabetes (SENSITIZE INDIA)Shashank Joshi, Monika Tandon, Rahul Kodgule, et al.
Frontiers in Endocrinology|December 5, 2024
Personalized nutrition in type 2 diabetes remission: application of digital twin technology for predictive glycemic controlParamesh Shamanna, Shashank Joshi, Mohamed Thajudeen, et al.
Journal of Technology in Behavioral Science|April 4, 2022
High School Educator Training by Simulation to Address Emotional and Behavioral Concerns in School Settings: A Randomized StudyGlenn Albright, Mina Fazel, Nikita Khalid, et al.
The Journal of the Association of Physicians of India|October 11, 2024
Blue Index as a Comprehensive, Patient-centered Assessment of Care in Diabetic PatientsRupak Chatterjee, Arindam Naskar, Shambo Samrat Samajdar, et al.
Diabetes Technology & Therapeutics|October 22, 2013
A multicenter, prospective, randomized, double-blind study to evaluate the safety and efficacy of Saroglitazar 2 and 4 mg compared with placebo in type 2 diabetes mellitus patients having hypertriglyceridemia not controlled with atorvastatin therapy (PRESS VI)Rajendrakumar H Jani, Vikas Pai, Pramod Jha, et al.
The Journal of the Association of Physicians of India|September 16, 2025
Ribavirin and IVIG Therapy for Severe hMPV Pneumonia: A Promising Therapeutic Approach for IndiaShambo S Samajdar, Rupak Chatterjee, Shatavisa Mukherjee, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 1, 2023
Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled StudyShashank Joshi, Paramesh Shamanna, Mala Dharmalingam, et al.
Pageof 12